Works matching DE "EMTRICITABINE-tenofovir"


Results: 357
    1
    2
    3
    4
    5
    7
    8
    9
    10
    11
    12

    Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis.

    Published in:
    Journal of Infectious Diseases, 2015, v. 211, n. 8, p. 1211, doi. 10.1093/infdis/jiu677
    By:
    • Lehman, Dara A.;
    • Baeten, Jared M.;
    • McCoy, Connor O.;
    • Weis, Julie F.;
    • Peterson, Dylan;
    • Mbara, Gerald;
    • Donnell, Deborah;
    • Thomas, Katherine K.;
    • Hendrix, Craig W.;
    • Marzinke, Mark A.;
    • Frenkel, Lisa;
    • Ndase, Patrick;
    • Mugo, Nelly R.;
    • Celum, Connie;
    • Overbaugh, Julie;
    • Matsen, Frederick A.
    Publication type:
    Article
    13

    HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial.

    Published in:
    Journal of Infectious Diseases, 2014, v. 210, n. 8, p. 1217, doi. 10.1093/infdis/jiu233
    By:
    • Liegler, Teri;
    • Abdel-Mohsen, Mohamed;
    • Bentley, L. Gordon;
    • Atchison, Robert;
    • Schmidt, Timothy;
    • Javier, Jacqueline;
    • Mehrotra, Megha;
    • Eden, Christopher;
    • Glidden, David V.;
    • McMahan, Vanessa;
    • Anderson, Peter L.;
    • Li, Peilin;
    • Wong, Joseph K.;
    • Buchbinder, Susan;
    • Guanira, Juan V.;
    • Grant, Robert M.
    Publication type:
    Article
    14
    15

    Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results.

    Published in:
    Journal of Infectious Diseases, 2013, v. 208, n. 1, p. 32, doi. 10.1093/infdis/jit122
    By:
    • Gallant, Joel E.;
    • Koenig, Ellen;
    • Andrade-Villanueva, Jaime;
    • Chetchotisakd, Ploenchan;
    • DeJesus, Edwin;
    • Antunes, Francisco;
    • Arastéh, Keikawus;
    • Moyle, Graeme;
    • Rizzardini, Giuliano;
    • Fehr, Jan;
    • Liu, Yapei;
    • Zhong, Lijie;
    • Callebaut, Christian;
    • Szwarcberg, Javier;
    • Rhee, Martin S.;
    • Cheng, Andrew K.
    Publication type:
    Article
    16

    Changes in Fat Mitochondrial DNA and Function in Subjects Randomized to Abacavir-Lamivudine or Tenofovir DF–Emtricitabine With Atazanavir-Ritonavir or Efavirenz: AIDS Clinical Trials Group Study A5224s, Substudy of A5202.

    Published in:
    Journal of Infectious Diseases, 2013, v. 207, n. 4, p. 604, doi. 10.1093/infdis/jis720
    By:
    • McComsey, Grace A.;
    • Daar, Eric S.;
    • O'Riordan, MaryAnn;
    • Collier, Ann C.;
    • Kosmiski, Lisa;
    • Santana, Jorge L.;
    • Fichtenbaum, Carl J.;
    • Fink, Heidi;
    • Sax, Paul E.;
    • Libutti, Daniel E.;
    • Gerschenson, Mariana
    Publication type:
    Article
    17
    18
    19

    Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa.

    Published in:
    PLoS Medicine, 2013, v. 10, n. 9, p. 1, doi. 10.1371/journal.pmed.1001511
    By:
    • Haberer, Jessica E.;
    • Baeten, Jared M.;
    • Campbell, James;
    • Wangisi, Jonathan;
    • Katabira, Elly;
    • Ronald, Allan;
    • Tumwesigye, Elioda;
    • Psaros, Christina;
    • Safren, Steven A.;
    • Ware, Norma C.;
    • Thomas, Katherine K.;
    • Donnell, Deborah;
    • Krows, Meighan;
    • Kidoguchi, Lara;
    • Celum, Connie;
    • Bangsberg, David R.
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.

    Published in:
    Transgender Health, 2024, v. 9, n. 1, p. 46, doi. 10.1089/trgh.2022.0048
    By:
    • Cespedes, Michelle S.;
    • Das, Moupali;
    • Yager, Jenna;
    • Prins, Maria;
    • Krznaric, Ivanka;
    • de Jong, Jan;
    • Xiao, Deqing;
    • Shao, Yongwu;
    • Wong, Pamela;
    • Kintu, Alexander;
    • Carter, Christoph;
    • Hoornenborg, Elske;
    • Ruane, Peter;
    • Phoenix, John;
    • Younis, Islam;
    • Halperin, Jason
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Mobilization of systemic CCL4 following HIV preexposure prophylaxis in young men in Africa.

    Published in:
    Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.965214
    By:
    • Petkov, Stefan;
    • Herrera, Carolina;
    • Else, Laura;
    • Mugaba, Susan;
    • Namubiru, Patricia;
    • Odoch, Geoffrey;
    • Opoka, Daniel;
    • Pillay, Azure-Dee A. P.;
    • Seiphetlo, Thabiso B.;
    • Serwanga, Jennifer;
    • Ssemata, Andrew S.;
    • Kaleebu, Pontiano;
    • Webb, Emily L.;
    • Khoo, Saye;
    • Lebina, Limakatso;
    • Gray, Clive M.;
    • Martinson, Neil;
    • Fox, Julie;
    • Chiodi, Francesca
    Publication type:
    Article
    37
    39
    40
    41
    42
    43
    44
    45

    A Latent Class Analysis of Risk Factors for Acquiring HIV Among Men Who Have Sex with Men: Implications for Implementing Pre-Exposure Prophylaxis Programs.

    Published in:
    AIDS Patient Care & STDs, 2015, v. 29, n. 11, p. 597, doi. 10.1089/apc.2015.0113
    By:
    • Chan, Philip A.;
    • Rose, Jennifer;
    • Maher, Justine;
    • Benben, Stacey;
    • Pfeiffer, Kristen;
    • Almonte, Alexi;
    • Poceta, Joanna;
    • Oldenburg, Catherine E.;
    • Parker, Sharon;
    • Marshall, Brandon DL;
    • Lally, Mickey;
    • Mayer, Kenneth;
    • Mena, Leandro;
    • Patel, Rupa;
    • Nunn, Amy S.
    Publication type:
    Article
    46
    47
    48
    49
    50